Skip to Content
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 31, 2016 ($M)
  • Previous Rank
  • Morning Consult Brand Index

Cardinal Health, a drug wholesaler that also makes gloves and surgical apparel, has been shoring up its future earnings through a series of strategic acquisitions, development of its alternate care business, and promotion of its specialty drug assets. The company has spent $5.7 billion on acquisitions since 2011, including paying $1.94 billion for Johnson & Johnson’s Cordis heart-product business. The deal closed ahead of schedule in late 2015. Along with the Cordis integration and a recent deal with Henry Shein, Cardinal Health will also be focused on its Red Oak venture over the next year. The 10-year split generics buying operation with CVS is a strong earnings booster. The partnerships and purchases are a way for Cardinal Health to snag a greater share of the medical products sold to hospitals, physicians, and ambulatory centers.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

George S. Barrett
Health Care
Wholesalers: Health Care
HQ Location
Dublin, OH
Years on Fortune 500 List22
Figures are for fiscal year ended June 30, 2015.

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$102,53112.6%
Profits ($M)$1,2154.2%
Assets ($M)$30,142-
Total Stockholder Equity ($M)$6,256-
Market Value — as of March 31, 2016 ($M)$26,989-

Profit Ratios

Profit as % of Revenues1.2%
Profits as % of Assets4%
Profits as % of Stockholder Equity19.4%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.62
EPS % Change (from 2014)7.1%
EPS % Change (5 year annual rate)15.4%
EPS % Change (10 year annual rate)4.2%

Total Return

Total Return to Investors (2015)12.6%
Total Return to Investors (5 year, annualized)20.9%
Total Return to Investors (10 year, annualized)7.8%